Search clinical trials for: Lenvatinib 24 mg

Total 11314 results

Eisai Inc.

Terminated

A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)

Thyroid Carcinoma, Anaplastic

Italy, United States, France, Australia, United Kingdom
Repros Therapeutics Inc.

Completed

Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200

Uterine Fibroids
Boehringer Ingelheim

Completed

Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type

Alzheimer Disease
Guangzhou Magpie Pharmaceuticals Co., Ltd.

Not yet recruiting

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets

Pulmonary Arterial Hypertension
Aviragen Therapeutics

Completed

A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy Volunteers

Healthy

United States
Repros Therapeutics Inc.

Completed

Extension of Study ZPV-200

Uterine Fibroids

United States
UCB Biopharma SRL

Terminated

A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome

Restless Legs Syndrome

United States
Watson Pharmaceuticals

Completed

Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis

Hyperhidrosis

United States
Sunovion

Completed

Dasotraline SEP360-105 Pediatric PK/PD Study

Pediatric Attention Deficit Hyperactivity Disorder

United States
Shanghai Zhongshan Hospital
West China Hospital; Tongji Hospital; Anhui Provincial Hospital

Unknown

Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC

Hepatocellular Carcinoma (HCC)

China
Shanghai Zhongshan Hospital
West China Hospital; Tongji Hospital; Anhui Provincial Hospital

Unknown

Efficacy and Safety of Lenvatinib as an Adjuvant Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

China
Regeneron Pharmaceuticals
Syneos Health

Withdrawn

Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia

Anemia | Chronic Kidney Disease

United States
Eisai Inc.

Completed

Bioequivalence Study to Evaluate the Impact of Varying Crystalline Polymorph Forms for the Commercial Oral Capsule Formulation of 10-mg Lenvatinib in Healthy Volunteers

Healthy Volunteers

United States
Chang Gung Memorial Hospital
Ministry of Health and Welfare, Taiwan

Recruiting

Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma

High Risk of Recurrence

Taiwan
University of Toronto
Canadian Institutes of Health Research (CIHR)

Completed

The Nitrate and Bone Study: Effects of Nitrates on Osteoporosis

Osteoporosis

Canada
UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Healthy

Germany
Novartis

Completed

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 (ACTION)

Alzheimer's Disease

United States, Puerto Rico
Shanghai Zhongshan Hospital

Enrolling by invitation

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

Hepatocellular Carcinoma

China
Montefiore Medical Center
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults

Juvenile Idiopathic Arthritis

United States
Swiss Tropical & Public Health Institute
Public Health Laboratory Ivo de Carneri

Completed

Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura (MOXIDOSE)

Trichuris Trichiura; Infection

Tanzania
HALEON

Completed

A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects

Pain

Czechia
Luye Pharma Group Ltd.
SocraTec R&D GmbH; SocraMetrics GmbH

Completed

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)

Healthy

Germany
Annick Desjardins
Symphogen A/S

Completed

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

Malignant Glioma

United States
Memorial Sloan Kettering Cancer Center

Completed

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Head and Neck Carcinoma | Cutaneous Squamous Cell Carcinoma

United States
SocraTec R&D GmbH
SocraMetrics GmbH

Completed

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

Bioequivalence

Germany
SocraTec R&D GmbH

Completed

Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h)

Bioequivalence

Germany
SocraTec R&D GmbH
SocraMetrics GmbH

Completed

Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase

Bioequivalence

Germany
Eisai Inc.

Completed

A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval

Lymphomas | Refractory Solid Tumors

United States
Eisai Co., Ltd.
Merck Sharp & Dohme LLC

Completed

A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States, Spain, France, Italy, Japan, Russian Federation, United Kingdom
MedSIR
Merck Sharp & Dohme LLC

Active, not recruiting

Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents (PECATI)

Metastatic Thymic Carcinoma | Thymoma Type B3

Spain, France, Italy
Fujian Cancer Hospital

Not yet recruiting

A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses

Hepatocellular Carcinoma
Yonsei University

Not yet recruiting

Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations (LU21-16)

NSCLC

Korea, Republic of
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg

Healthy

United States
Baylor College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Fit 24 Technology Intervention YOUTH

Diabetes Mellitus, Type 2

United States
Oihana Lopez Alonso

Completed

Comparison of the Efficacy of Oral Sucrose Administration at Two Different Times of a Painful Procedure in Neonates.

Pain

Spain
ANRS, Emerging Infectious Diseases

Completed

DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) (DRIVE-C)

Hepatitis C | Viral Hepatitis C | Drug Use

Vietnam
RenJi Hospital

Recruiting

Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 ) (Dulect2020-1)

Liver Transplant; Complications | Liver Carcinoma

China
Fudan University

Active, not recruiting

Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Peking Union Medical College Hospital

Recruiting

Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Biliary Tract Neoplasms Immunotherapy

China
University of Southern California
Children's Bureau - Administration for Children and Families; The Children's...

Enrolling by invitation

Improving Father-Child and Father-Partner Relationships Among Black and Hispanic Fathers

Parent-Child Relations | Parenting | Partner Communication

United States
AC Immune SA

Withdrawn

A Study of ACI-24 in Adults With Down Syndrome

Down Syndrome
Regina Elena Cancer Institute
University of Pisa; University of Roma La Sapienza; University of Turin, Italy; Istituto Oncologico Veneto IRCCS and other collaborators

Recruiting

Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer (Gisel)

Differentiated Thyroid Cancer | Gender

Italy
Hoffmann-La Roche

Completed

A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma

HIV Infections | Sarcoma, Kaposi

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance (GANCIMVEAR)

Congenital Cytomegalovirus (CMV)

France
University Hospital, Rouen

Not yet recruiting

Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease (ETERNAL-PKD)

Kidney Diseases
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC

Advanced Hepatocellular Carcinoma (HCC)

Italy, Poland, Singapore, United States, China, Ukraine
Revaz Dzhindzhikhadze

Not yet recruiting

Early Versus Ultra Early Surgical Treatment of Ruptured Intracranial Aneurysms

Aneurysmal Subarachnoid Hemorrhage
Shandong New Time Pharmaceutical Co., LTD

Recruiting

the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Active, not recruiting

Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC

Hepatocellular Carcinoma | Radiotherapy | Lenvatinib

China

3

Subscribe